A Mississippi federal judge has denied a request from Novartis Pharmaceuticals and the Pharmaceutical Research and Manufacturers of America for a preliminary injunction against state enforcement protecting 340B pricing for contract pharmacies.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
